MLKN vs REGN · P/E 15, rev $3.67B vs P/E 14, rev $14.34B
MillerKnoll Inc (MLKN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
MillerKnoll Inc (MLKN) is a furnishings, fixtures & appliances company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MLKN revenue for 2025-05-31 was $3.67B. Net income was -$33.2M. Revenue was up 1.1% from 2024-06-01 to 2025-05-31. MLKN currently screens at market cap $1.39B and trailing P/E 15.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MLKN currently screens at market cap $1.39B and trailing P/E 15.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MLKN and REGN stock pages for the full models.
Not investment advice.